Brespas 20mg/250mg Tablet
By Brespas
Rx
10 Tablet in a Strip

Composition
Dicyclomine(20mg) + Mefenamic Acid(250mg)

Manufacturer - Brance Biotech
SCF- 368 Second Floor, Motor Market Manimajra Chandigarh {U.T.}

Expires on or after
September, 2025

liver
When taking Brespas 20mg/250mg Tablet, it is important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment of this medication. It is advised to consult with your doctor before using Brespas 20mg/250mg Tablet to ensure appropriate precautions are taken.

kidney
Brespas 20mg/250mg Tablet should be used carefully in patients with kidney disease. Dosage adjustment may be necessary, so consult your doctor. Avoid use in severe kidney disease.

alcohol
Caution is advised about consuming alcohol with Brespas 20mg/250mg Tablet. It's important to consult your doctor for guidance.

driving
It is not clear if Brespas 20mg/250mg Tablet affects driving ability. Refrain from driving if you have symptoms that interfere with concentration and reaction time.

pregnancy
It is better to consult your doctor before using Brespas 20mg/250mg Tablet during pregnancy.

breastfeeding
It is better to consult your doctor before using Brespas 20mg/250mg Tablet during breastfeeding.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | PAIN ANALGESICS |
Action Class | - |
₹25
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 11-Feb-2025